Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMOFlipid in Short-term Parenteral Nutrition in Pediatric Onco-Hematology
NCT02539316Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Jun 2015
- Primary completion
- Oct 2016
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 4 trial of SMOFlipid in cholestasis, hepatotoxicity, sponsored by Centre Hospitalier Universitaire de Nice. Started Jun 2015; status: completed.
02
Drugs
SMOFlipid
03
Conditions
cholestasishepatotoxicity
Beyond the preview
Go deeper on NCT02539316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02539316.